WP backs fourth pharma spin-out
Warburg Pincus has provided E60m in funding for the bone disease research division of French pharmaceutical giant Aventis.
30 December 2012•2 mins read
Warburg Pincus has provided E60m in funding for the bone disease research division of French pharmaceutical giant Aventis.
Bridgepoint taps former RAF chief in €1bn defense strategy launch
10 November 2026 · 4 mins read
Stacking up: How PE performs in each region
10 November 2026 · 2 mins read
Side Letter: Exits and earnings
9 November 2026 · 3 mins read
Private Take: Reading beyond the scoreboard
9 November 2026 · 4 mins read
PEI Private Equity Awards 2026: Send us your highlights!
5 November 2026 · 6 mins read
Side Letter: Markdowns, moratoriums
5 November 2026 · 2 mins read
AllianzGI leaves door open for reversal of PE pullback
5 November 2026 · 2 mins read
